Form 8-K - Current report:
SEC Accession No. 0001193805-22-001285
Filing Date
2022-09-20
Accepted
2022-09-20 08:04:49
Documents
72
Period of Report
2022-09-20
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 e621930_8k-immunic.htm   iXBRL 8-K 19030
2 PRESS RELEASE, DATED SEPTEMBER 20, 2022 e621930_ex99-1.htm EX-99.1 21761
3 PRESENTATION, DATED SEPTEMBER 20, 2022 e621930_ex99-2.htm EX-99.2 41020
7 GRAPHIC logo.jpg GRAPHIC 5779
8 GRAPHIC slide1.jpg GRAPHIC 285000
9 GRAPHIC slide2.jpg GRAPHIC 320809
10 GRAPHIC slide3.jpg GRAPHIC 156397
11 GRAPHIC slide4.jpg GRAPHIC 85742
12 GRAPHIC slide5.jpg GRAPHIC 77608
13 GRAPHIC slide6.jpg GRAPHIC 62853
14 GRAPHIC slide7.jpg GRAPHIC 182802
15 GRAPHIC slide8.jpg GRAPHIC 64925
16 GRAPHIC slide9.jpg GRAPHIC 112868
17 GRAPHIC slide10.jpg GRAPHIC 165295
18 GRAPHIC slide11.jpg GRAPHIC 125694
19 GRAPHIC slide12.jpg GRAPHIC 87502
20 GRAPHIC slide13.jpg GRAPHIC 65293
21 GRAPHIC slide14.jpg GRAPHIC 123548
22 GRAPHIC slide15.jpg GRAPHIC 174361
23 GRAPHIC slide16.jpg GRAPHIC 154091
24 GRAPHIC slide17.jpg GRAPHIC 189510
25 GRAPHIC slide18.jpg GRAPHIC 138190
26 GRAPHIC slide19.jpg GRAPHIC 150515
27 GRAPHIC slide20.jpg GRAPHIC 140419
28 GRAPHIC slide21.jpg GRAPHIC 130008
29 GRAPHIC slide22.jpg GRAPHIC 127902
30 GRAPHIC slide23.jpg GRAPHIC 94634
31 GRAPHIC slide24.jpg GRAPHIC 64979
32 GRAPHIC slide25.jpg GRAPHIC 195582
33 GRAPHIC slide26.jpg GRAPHIC 219753
34 GRAPHIC slide27.jpg GRAPHIC 194205
35 GRAPHIC slide28.jpg GRAPHIC 141806
36 GRAPHIC slide29.jpg GRAPHIC 47736
37 GRAPHIC slide30.jpg GRAPHIC 205862
38 GRAPHIC slide31.jpg GRAPHIC 187585
39 GRAPHIC slide32.jpg GRAPHIC 128502
40 GRAPHIC slide33.jpg GRAPHIC 58966
41 GRAPHIC slide34.jpg GRAPHIC 153910
42 GRAPHIC slide35.jpg GRAPHIC 150687
43 GRAPHIC slide36.jpg GRAPHIC 157958
44 GRAPHIC slide37.jpg GRAPHIC 59743
45 GRAPHIC slide38.jpg GRAPHIC 152136
46 GRAPHIC slide39.jpg GRAPHIC 148941
47 GRAPHIC slide40.jpg GRAPHIC 159180
48 GRAPHIC slide41.jpg GRAPHIC 130652
49 GRAPHIC slide42.jpg GRAPHIC 130575
50 GRAPHIC slide43.jpg GRAPHIC 131392
51 GRAPHIC slide44.jpg GRAPHIC 124795
52 GRAPHIC slide45.jpg GRAPHIC 123628
53 GRAPHIC slide46.jpg GRAPHIC 124722
54 GRAPHIC slide47.jpg GRAPHIC 101179
55 GRAPHIC slide48.jpg GRAPHIC 132983
56 GRAPHIC slide49.jpg GRAPHIC 142599
57 GRAPHIC slide50.jpg GRAPHIC 145746
58 GRAPHIC slide51.jpg GRAPHIC 122726
59 GRAPHIC slide52.jpg GRAPHIC 130100
60 GRAPHIC slide53.jpg GRAPHIC 122097
61 GRAPHIC slide54.jpg GRAPHIC 134020
62 GRAPHIC slide55.jpg GRAPHIC 76877
63 GRAPHIC slide56.jpg GRAPHIC 158729
64 GRAPHIC slide57.jpg GRAPHIC 97129
  Complete submission text file 0001193805-22-001285.txt   10982808

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA imux-20220920.xsd EX-101.SCH 3215
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE imux-20220920_lab.xml EX-101.LAB 34240
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE imux-20220920_pre.xml EX-101.PRE 22351
66 EXTRACTED XBRL INSTANCE DOCUMENT e621930_8k-immunic_htm.xml XML 3695
Mailing Address 1200 AVENUE OF THE AMERICAS SUITE 200 NEW YORK X1 10036
Business Address 1200 AVENUE OF THE AMERICAS SUITE 200 NEW YORK X1 10036 (332) 255-9818
IMMUNIC, INC. (Filer) CIK: 0001280776 (see all company filings)

EIN.: 562358443 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36201 | Film No.: 221252099
SIC: 2834 Pharmaceutical Preparations